Lutetium-(177Lu)-oxodotreotideRenal impairment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2022卷 / 1期

关键词：

D O I：

10.1007/s40278-024-65483-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：163 / 163

相关论文

共 50 条

[31] Lutetium-(177lu)-oxodotreotideBone marrow dysplasia: case report
Reactions Weekly, 2022, 1934 (1) : 264 - 264
[32] Lutetium-(177Lu)-oxodotreotideGrade 3 thrombocytopenia: case report
Reactions Weekly, 2020, 1830 (1) : 205 - 205
[33] Lutetium-(177Lu)-oxodotreotideAnaemia
Reactions Weekly, 2023, 1986 (1) : 248 - 248
[34] Lutetium-(177Lu)-oxodotreotideHypothyroidism
Reactions Weekly, 2023, 1984 (1) : 313 - 313
[35] Lutetium-(177lu)-oxodotreotideAcute myeloid leukaemia: case report
Reactions Weekly, 2020, 1817 (1) : 199 - 199
[36] Lutetium-(177Lu)-oxodotreotideInjection site extravasation: case report
Reactions Weekly, 2021, 1858 (1) : 232 - 232
[37] Lutetium-(177lu)-oxodotreotideFirst report of acute pancreatitis: case report
Reactions Weekly, 2018, 1711 (1) : 179 - 179
[38] Lutetium-(177Lu)-vipivotide-tetraxetanLack of efficacy: case report
Reactions Weekly, 2024, 2035 (1) : 270 - 270
[39] Lutetium-(177lu)-oxodotreotideAcute disseminated intravascular coagulation: case report
Reactions Weekly, 2023, 1955 (1) : 229 - 229
[40] Carboplatin/etoposide/lutetium-(177Lu)-oxodotreotideMyelodysplastic syndrome: case report
Reactions Weekly, 2020, 1789 (1) : 83 - 83

← 1 2 3 4 5 →